Tempus AI, Inc. (NASDAQ:TEM) Receives $63.42 Average Price Target from Analysts

Tempus AI, Inc. (NASDAQ:TEMGet Free Report) has received a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are presently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $63.58.

A number of research analysts have recently issued reports on TEM shares. Morgan Stanley boosted their target price on Tempus AI from $60.00 to $65.00 and gave the company an “overweight” rating in a report on Friday, May 9th. Bank of America boosted their target price on Tempus AI from $68.00 to $70.00 and gave the company a “neutral” rating in a report on Wednesday. Piper Sandler boosted their target price on Tempus AI from $55.00 to $70.00 and gave the company a “neutral” rating in a report on Thursday, May 15th. Needham & Company LLC reissued a “buy” rating and issued a $70.00 target price on shares of Tempus AI in a report on Wednesday, May 7th. Finally, BTIG Research started coverage on Tempus AI in a report on Monday, April 21st. They issued a “buy” rating and a $60.00 target price on the stock.

Get Our Latest Report on Tempus AI

Insider Buying and Selling

In other Tempus AI news, CAO Ryan M. Bartolucci sold 6,073 shares of the company’s stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $63.23, for a total value of $383,995.79. Following the sale, the chief accounting officer now owns 47,799 shares of the company’s stock, valued at approximately $3,022,330.77. This represents a 11.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Andrew Polovin sold 17,552 shares of the company’s stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $63.43, for a total value of $1,113,323.36. Following the completion of the sale, the executive vice president now directly owns 138,877 shares in the company, valued at $8,808,968.11. This trade represents a 11.22% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 609,897 shares of company stock valued at $41,397,783 over the last quarter. Company insiders own 27.60% of the company’s stock.

Institutional Trading of Tempus AI

Large investors have recently bought and sold shares of the company. Victory Capital Management Inc. acquired a new stake in Tempus AI in the fourth quarter valued at $216,000. Wells Fargo & Company MN grew its holdings in Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock valued at $80,000 after purchasing an additional 278 shares during the last quarter. SeaCrest Wealth Management LLC acquired a new stake in Tempus AI in the first quarter valued at $535,000. ProShare Advisors LLC acquired a new stake in Tempus AI in the fourth quarter valued at $244,000. Finally, Avanza Fonder AB lifted its position in shares of Tempus AI by 15.8% in the first quarter. Avanza Fonder AB now owns 41,005 shares of the company’s stock valued at $2,047,000 after acquiring an additional 5,591 shares in the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Price Performance

Shares of NASDAQ TEM opened at $68.34 on Tuesday. The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 2.45. Tempus AI has a twelve month low of $27.68 and a twelve month high of $91.45. The stock has a 50 day moving average of $60.74 and a two-hundred day moving average of $53.15. The stock has a market cap of $11.83 billion and a P/E ratio of -8.76.

Tempus AI (NASDAQ:TEMGet Free Report) last released its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.03. The business had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The business’s revenue was up 75.4% on a year-over-year basis. On average, research analysts forecast that Tempus AI will post -6.15 earnings per share for the current year.

Tempus AI Company Profile

(Get Free Report

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Featured Articles

Analyst Recommendations for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.